Rajan P. Adhikari
Rajan P. Adhikari publishes mostly in Infectious Diseases, Molecular Biology and Public Health, Environmental and Occupational Health, on topics such as Antimicrobial Resistance in Staphylococcus, Bacterial biofilms and quorum sensing and Streptococcal Infections and Treatments.
- World rank
- #1,365,107 of 7,710,434 ranked researchers
- Rank in United States
- #432,170 of 1,627,098
- Works
- 37
- Citations
- 1.6k
- Citations per work
- 42.3
What does Rajan P. Adhikari research?
Rajan P. Adhikari's work is mostly in Medicine (44%), Biochemistry, Genetics and Molecular Biology (30%), Immunology and Microbiology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1643.8%
- Medicine1643.8%
- Life Sciences1541.1%
- Everything else615.1%
- 1Infectious Diseases36% of their works
- 2Molecular Biology25% of their works
- 3Public Health, Environmental and Occupational Health8% of their works
- 4Immunology7% of their works
- 5Genetics5% of their works
- 6Microbiology5% of their works
Research topics
- Antimicrobial Resistance in Staphylococcus
- Bacterial biofilms and quorum sensing
- Streptococcal Infections and Treatments
- Clostridium difficile and Clostridium perfringens research
- Biochemical and Structural Characterization
- Bacterial Genetics and Biotechnology
- Antimicrobial Peptides and Activities
- Bacteriophages and microbial interactions
Which keywords describe Rajan P. Adhikari's research?
The keywords of their largest research topics: Epidemiology, Virulence Factors, Healthcare-Associated Infections, MRSA, Staphylococcus aureus, Antibiotic Resistance, Bacteria and Biofilms.
- Virus
- Ecology
- Gene Regulation
- Sortase
- Fecal Microbiota Transplantation
- Streptococcus Pyogenes
- Biofilms
- Antibiotic Resistance
- MRSA
- Virulence Factors
- Epidemiology
- Healthcare-Associated Infections
- Staphylococcus aureus
- Bacteria
- Necrotizing Fasciitis
- Antibiotic-Associated Diarrhea
- Cyclotides
- Bacterial Physiology
- Antimicrobial Peptides
- Host Defense
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Epidemiology443 topics
- Virulence Factors372 topics
- Healthcare-Associated Infections362 topics
- MRSA291 topic
- Staphylococcus aureus291 topic
- Antibiotic Resistance192 topics
- Bacteria141 topic
- Biofilms141 topic
- Necrotizing Fasciitis81 topic
- Streptococcus Pyogenes81 topic
- Antibiotic-Associated Diarrhea71 topic
- Fecal Microbiota Transplantation71 topic
- Cyclotides61 topic
- Sortase61 topic
- Bacterial Physiology51 topic
- Gene Regulation51 topic
- Antimicrobial Peptides41 topic
- Ecology41 topic
- Host Defense41 topic
- Virus41 topic
Where does Rajan P. Adhikari work?
Rajan P. Adhikari's main affiliation in the publication record is Integrated BioTherapeutics (United States), United States.
How many publications and citations does Rajan P. Adhikari have?
OpenAlex counts 37 works and 1,565 citations for Rajan P. Adhikari, an h-index of 19, ranking #1,365,107 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Rajan P. Adhikari. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.